The AJMC® Ophthalmology compendium is a comprehensive resource for clinical news and expert insights for treatment of disorders of the eye.
September 17th 2025
Although children living with myopia taking atropine did experience an increased incidence of cataracts, glaucoma, or maculopathy, it is unclear if this risk was confounded by myopia severity.
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
1 Credit / Cardiology, Neurology
View More
The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes
1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry
View More
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
View More
Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care
1.5 Credits / Ophthalmology/Optometry
View More
Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies
1.5 Credits / Ophthalmology/Optometry
View More
Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)
1.5 Credit / Ophthalmology/Optometry
View More
Leveraging Novel Therapies to Transform Demodex Blepharitis Care
1.5 Credit / Ophthalmology/Optometry
View More
Teleophthalmology Is Here Today, but Insurance Coverage, Reimbursement Will Change
August 17th 2022Insurance reimbursement for teleophthalmology services is not consistent among populations and only recently received a boost due to flexibilities allowed during the pandemic, said Parisa Emami-Naeini, MD, MPH, assistant professor of ophthalmology at University of California, Davis, and vitreoretinal surgeon and uveitis specialist at UC Davis Eye Center.
Watch
Dr Vivienne Hau Highlights the Need for Better Trial Design for Patient Diversity
August 2nd 2022Getting a more diverse patient population in clinical trials may be as simple as including paperwork in more languages, but good training among investigators and study coordinators can help identify unconscious biases that may also have an impact, explained Vivienne Hau, MD, clinical assistant professor with the Kaiser Permanente Bernard J. Tyson School of Medicine.
Watch
Dr Sabin Dang Discusses the Impact of Delayed Treatment in Retina Diseases
July 25th 2022In retina surgery, obtaining prior authorization is an extra burden, and a delay in treatment for some of these patients could mean loss of vision, said Sabin Dang, MD, ophthalmologist with The Retina Institute.
Watch
Using AI to Screen for Preventable Infant Blindness in Underresourced Countries
July 18th 2022A recent study examined whether an artificial intelligence (AI) trained risk model could screen for retinopathy of prematurity, a leading cause of preventable blindness in infants in low- and middle-income countries, via telehealth.
Read More
Chart-Based Visual Function Tests Limited in Detecting Intermediate AMD
June 28th 2022A noninterventional study found that chart-based assessments of visual function had adequate repeatability but were limited in discriminating between no age-related macular degeneration (AMD) and intermediate AMD.
Read More
Analysis Finds Ranibizumab PDS Cost-Saving in Long-term Scenarios
June 22nd 2022A recent study found that the ranibizumab port delivery system (PDS) has cost-saving potential compared with regular ranibizumab or aflibercept injections for age-related macular degeneration if used in the long term.
Read More
Dr Steven Yeh Discusses Future of Suprachoroidal Drug Delivery
May 25th 2022Steven Yeh, MD, professor of ophthalmology at the Truhlsen Eye Institute at the University of Nebraska Medical Center, talks about what he sees in the future of suprachoroidal administration and other unmet needs in ophthalmology.
Watch
Dr Steven Yeh Explains Xipere Follow-up Findings, Learning Curves for Clinicians
May 2nd 2022Steven Yeh, MD, professor of ophthalmology at the Truhlsen Eye Institute at the University of Nebraska Medical Center, discusses the length of Xipere's treatment benefits and potential learning curves regarding its suprachoroidal delivery mechanism.
Watch
RNA Sequencing Identifies Novel, Specific Biomarkers in Pterygia
May 1st 2022While risk factors for pterygia are well-known, the underlying disease mechanisms have not been fully clarified in past studies. A new analysis using RNA sequencing pinpointed ptergyia-specific biomarkers and potential therapeutic targets.
Read More
Patients may have unrealistic expectations of how a new treatment or procedure may help them, and the conversation between the patient and physician is crucial for setting expectations, explained Robert G. Fante, MD, FACS, president of the American Society of Ophthalmic Plastic & Reconstructive Surgery and facial plastic surgeon and cosmetic surgeon, Fante Eye & Face Centre in Denver, Colorado.
Watch